To find out effect and safety of luliconazole and ketoconazole in patient with tinea versicolor disease
Phase 4
- Conditions
- Health Condition 1: B360- Pityriasis versicolor
- Registration Number
- CTRI/2023/07/055746
- Lead Sponsor
- Pt BD Sharma PGIMS Rohtak
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients of either gender over 18 years of age
2. Patients having lesions on face, neck and thorax
3. Patients with a clinical diagnosis of tinea versicolor, confirmed by microscopic KOH test
Exclusion Criteria
1. Pregnant and lactating females
2. Patients with:
i. Contact dermatitis, Atopic dermatitis or other skin diseases
ii. Other tinea infections
iii. Hypersensitivity to study drugs
iv. Therapy on other antifungal within a month
v. Serious concomitant illness
vi. Extensive tinea versicolor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method